S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
NASDAQ:MDVL

MedAvail (MDVL) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$1.80
$5.95
52-Week Range
N/A
Volume
245,100 shs
Average Volume
261,432 shs
Market Capitalization
$2.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MDVL stock logo

About MedAvail Stock (NASDAQ:MDVL)

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, and kiosk solutions in the United States and Canada. It offers a pharmacy technology solution, including the MedAvail MedCenter, which enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. The company is headquartered in Phoenix, Arizona. On February 2, 2024, MedAvail Holdings, Inc along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

MDVL Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Medavail Holdings Inc (MDVL)
MedAvail Holdings Inc Ordinary Shares MDVL
MedAvail Reports Second Quarter 2023 Financial Results
See More Headlines
Receive MDVL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAvail and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/08/2021
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Drug stores & proprietary stores
Sub-Industry
N/A
Current Symbol
NASDAQ:MDVL
Employees
279
Year Founded
N/A

Profitability

Net Income
$-47,620,000.00
Net Margins
-192.97%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$43.33 million
Book Value
$13.01 per share

Miscellaneous

Free Float
1,590,000
Market Cap
$2.91 million
Optionable
No Data
Beta
0.76
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Mr. Mark Doerr RPh (Age 54)
    CEO, President & Director
    Comp: $424.42k
  • Ms. Ramona Seabaugh (Age 55)
    CFO, Treasurer & Secretary
    Comp: $367.94k
  • Emilia Keric
    Senior VP & General Counsel
  • Ms. Joan O'Rourke
    President of SpotRx
  • Mr. Brian Schlerf
    Corporate Controller

MDVL Stock Analysis - Frequently Asked Questions

How were MedAvail's earnings last quarter?

MedAvail Holdings, Inc. (NASDAQ:MDVL) announced its quarterly earnings results on Monday, November, 8th. The company reported ($0.34) earnings per share for the quarter, missing the consensus estimate of ($0.32) by $0.02. The business earned $5.79 million during the quarter. MedAvail had a negative trailing twelve-month return on equity of 218.10% and a negative net margin of 192.97%. During the same period in the previous year, the firm earned ($0.84) earnings per share.

This page (NASDAQ:MDVL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners